1990 and Þ rst published an article on EBM in 1992. 2 The explosive growth of this new medical industry was well documented by David Sacket in an editorial in the British Medical Journal 4 years later, in which he noted the proliferation of conferences, topics, working groups, and academic programs. 3 Ironically, the limitations he noted at that time have been largely ignored, while the supposed beneÞ ts continue to be promoted.
The journal Plastic and Reconstructive Surgery has initiated a series of articles (63 articles, in fact) over the last decade, compiling an impressive assortment of EBM articles addressing speciÞ c plastic and cosmetic procedures. These articles are also used for continuing medical education, for maintenance of certiÞ cation, and, presumably, to create defensible standards of care. Critics of EBM note that there are certain built-in biases in the Þ eld, and I will point out several examples to be found in the December 2013 article on breast augmentation. 4 One of the basic principles of EBM is that it is drawn from a wide range of critically examined, statistically valid peer-reviewed published literature, focusing on those articles that offer the highest available evidence. The studies are then amalgamated to produce statistically signiÞ cant recommendations for diagnosis and treatment. The breast augmentation article, however, as an example, shows ß aws that include a limited review of the literature, exclusive use of English language publications, and a bias
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toward articles published in journals related to the American Society of Plastic Surgeons (ASPS), with Plastic Reconstructive Surgery and the Aesthetic Surgery Journal accounting for 57% of the references used to determine the best EBM (Table) . Additional sources used included several from Clinics that are curated but not peer reviewed in the usual sense and other databases.
Another characteristic of publications used for EBM is their high cost for either subscription or access to speciÞ c articles. For example, access to articles in Plastic Reconstructive Surgery depends either on ASPS membership or subscription payment, and it is the most costly of the aesthetic/cosmetic journals (Table) . If a nonsubscriber wishes to see an article from these publications, the cost varies from $20-$40 per article. Occasionally some articles may be available by open access or may be obtained from a library or a subscription to an aggregator source, such as ClinicalKey (part of Elsevier). Library resources such as Loansome Doc and Athens, in concert with PubMed can also provide access to full text. PubMed searches indicate which articles are available with full text for free.
The clinical practitioner, wishing to review best practices for breast augmentation according to EBM will have to spend signiÞ cant time validating the amalgamated studies or simply accept the validity of the article.
A more recent publication model is that of open access. Any journal publishing research funded by the federal government must be available without subscription. There has been an explosion of open access publishing, a good example of which is PLoS (Public Library of Science). 5 The founders of Wikipedia, Jimmy Wales and Larry Sanger, believed that information should be free. Additionally, they thought collaborative or "crowd" sourcing provided the best information over time, with few exceptions. Each post on Wikipedia is accompanied by a "history" page detailing who wrote what, when, and who changed it over time (some anonymous or collaborative), including a host of unpaid "professional" editors. The success of this model is probably best exempliÞ ed by the demise of the Encyclopedia Britannica, long a staple of home and library. Within 5 years of the start of Wikipedia, the print version of Encyclopedia Britannica was dead, and the online "wiki" model of authoring articles replaced the "expert" model of old. Reviews of Wikipedia reliability have appeared in several sources, including Nature 9 and, of course, in Wikipedia, 10 with the consensus that reliability is high, errors are corrected rapidly, and the few "bad" contributors are generally overridden by those with both good information and good intentions.
The value of the peer-reviewed, paid scientiÞ c subscription has been to support the cost of distributing information deemed valid by selected reviewers within a deÞ ned and generally speciÞ c area of knowledge. Our own journal, The American Journal of Cosmetic Surgery, has 10 different cosmetic surgery-related specialty sections with between 12 and 50 reviewers in each section. Open access challenges nearly all of traditional scientiÞ c publishing preconceptions. Open access publishing can be peer reviewed, but even more signiÞ cantly, peer reviewed by dozens if not hundreds of readers before and after posting, and can be updated, corrected, and revised over time. No longer do the opinions of a few select reviewers matter; now all involved readers matter, not just those who may have responded with a letter to the editor. Now, let's circle back to the opening discussion about medical decision making, who directs it, who pays for it, who controls it. The data being generated and collected in medical practice today are enormous. Out of this will come calls for physician ratings based on experience, complications, and patient satisfaction. Professional societies and legislative bodies will be called upon to determine the standards of care to which we will all be held. EBM is one of the tools to be used. It would seem only fair and proper that the literature that calls itself evidence-based, and the studies from which it is derived, should be available for consultation, education, and evaluation. Such vital information must be scrutinized, discussed widely, and debated openly if it is to fairly serve its purpose. Studies used in EBM summaries ought to be, as Cochrane requires, 11 institutional review board approved, based more on prospective than retrospective data, peer reviewed, derived from the global literature, not just English based, and statistically evaluated in detail. Both negative and positive research Þ ndings should be considered. Because such studies are so rare in the clinical literature, care should be taken in calling something EBM when it may still be primarily derived from weak data and opinion, more than from rigorous research. And, it should be free, not just freely available with paid subscriptions or pay per view.
References Used in Evidence-Based Medicine Articles on Breast Augmentation

